ITGAV & ITGB1 - Integrin alpha-V / Integrin beta-1 complex
Order number: 71231
Description
Introducing our off-the-shelf, full-length, active, and native complex of the Integrins
Alpha-V & Beta-1, also known as ITGAV/ITGB1.
These essential membrane proteins play a critical role in the development and progression of various diseases. Their role in cell adhesion, tissue remodeling, and cancer progression is closely tied to matrix interactions that support problematic overgrowths.
Our ITGAV/ITGB1 proteins are solubilized and stabilized using our innovative NativeMP™ platform. This ensures that the proteins retain their native structure and full biological activity, making them ideal for research applications in immunology, angiogenesis, and drug discovery.
Applications:
- Screening/Validation
- Biologics Development
- Structure Determination
- Small Molecule Drug Development
The proteins delivered can be used for these specific applications. When ordering, please indicate which applications you intend to use the proteins for in the contact form to ensure the best results.
For more details, explore our solubilization database.

Datasheets
Upon ordering, you will receive the corresponding datasheets and the Certificate of Analysis (CoA).
| Feature | |
|---|---|
| Alternative names ITGAV | ITGAV, CD51, MSK8, VNRA, VTNR |
| Alternative names ITGB1 | ITGB1, CD29 |
| UniProt Number | P06756 (ITGAV), P05556 (ITGB1) |
| Protein class | Integrin |
| Original host | Homo sapiens |
| Expression system | HEK293, Co-expression |
| Sequence, ITGAV-StrepII | MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEYSGPEGSYFGFAVDFFVPSASSRMFLLVGAPKANTTQPGIVEGGQVLKCDWSSTRRCQPIEFDATGNRDYAKDDPLEFKSHQWFGASVRSKQDKILACAPLYHWRTEMKQEREPVGTCFLQDGTKTVEYAPCRSQDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQGQLISDQVAEIVSKYDPNVYSIKYNNQLATRTAQAIFDDSYLGYSVAVGDFNGDGIDDFVSGVPRAARTLGMVYIYDGKNMSSLYNFTGEQMAAYFGFSVAATDINGDDYADVFIGAPLFMDRGSDGKLQEVGQVSVSLQRASGDFQTTKLNGFEVFARFGSAIAPLGDLDQDGFNDIAIAAPYGGEDKKGIVYIFNGRSTGLNAVPSQILEGQWAARSMPPSFGYSMKGATDIDKNGYPDLIVGAFGVDRAILYRARPVITVNAGLEVYPSILNQDNKTCSLPGTALKVSCFNVRFCLKADGKGVLPRKLNFQVELLLDKLKQKGAIRRALFLYSRSPSHSKNMTISRGGLMQCEELIAYLRDESEFRDKLTPITIFMEYRLDYRTAADTTGLQPILNQFTPANISRQAHILLDCGEDNVCKPKLEVSVDSDQKKIYIGDDNPLTLIVKAQNQGEGAYEAELIVSIPLQADFIGVVRNNEALARLSCAFKTENQTRQVVCDLGNPMKAGTQLLAGLRFSVHQQSEMDTSVKFDLQIQSSNLFDKVSPVVSHKVDLAVLAAVEIRGVSSPDHVFLPIPNWEHKENPETEEDVGPVVQHIYELRNNGPSSFSKAMLHLQWPYKYNNNTLLYILHYDIDGPMNCTSDMEINPLRIKISSLQTTEKNDTVAGQGERDHLITKRDLALSEGDIHTLGCGVAQCLKIVCQVGRLDRGKSAILYVKSLLWTETFMNKENQNHSYSLKSSASFNVIEFPYKNLPIEDITNSTLVTTNVTWGIQPAPMPVPVWVIILAVLAGLLLLAVLVFVMYRMGFFKRVRPPQEEQEREQLQPHENGEGNSETGGASWSHPQFEK |
| Sequence, ITGB1-Rho1D4 | MNLQPIFWIGLISSVCCVFAQTDENRCLKANAKSCGECIQAGPNCGWCTNSTFLQEGMPTSARCDDLEALKKKGCPPDDIENPRGSKDIKKNKNVTNRSKGTAEKLKPEDITQIQPQQLVLRLRSGEPQTFTLKFKRAEDYPIDLYYLMDLSYSMKDDLENVKSLGTDLMNEMRRITSDFRIGFGSFVEKTVMPYISTTPAKLRNPCTSEQNCTSPFSYKNVLSLTNKGEVFNELVGKQRISGNLDSPEGGFDAIMQVAVCGSLIGWRNVTRLLVFSTDAGFHFAGDGKLGGIVLPNDGQCHLENNMYTMSHYYDYPSIAHLVQKLSENNIQTIFAVTEEFQPVYKELKNLIPKSAVGTLSANSSNVIQLIIDAYNSLSSEVILENGKLSEGVTISYKSYCKNGVNGTGENGRKCSNISIGDEVQFEISITSNKCPKKDSDSFKIRPLGFTEEVEVILQYICECECQSEGIPESPKCHEGNGTFECGACRCNEGRVGRHCECSTDEVNSEDMDAYCRKENSSEICSNNGECVCGQCVCRKRDNTNEIYSGKFCECDNFNCDRSNGLICGGNGVCKCRVCECNPNYTGSACDCSLDTSTCEASNGQICNGRGICECGVCKCTDPKFQGQTCEMCQTCLGVCAEHKECVQCRAFNKGEKKDTCTQECSYFNITKVESRDKLPQPVQPDPVSHCKEKDVDDCWFYFTYSVNGNNEVMVHVVENPECPTGPDIIPIVAGVVAGIVLIGLALLLIWKLLMIIHDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGKGSSGTETSQVAPA |
| Affinity tags | ITGAV-StrepII (C-terminal); ITGB1-Rho1D4-tag (C-terminal) |
| Size ITGAV | 1060 amino acids, 117 kDa |
| Size ITGB3 | 811 amino acids, 90 kDa |
| Concentration | 0.4 - 0.7 mg/mL |
| Purity | >90%, determined via SDS-PAGE |
| Purification process | 3-step purification |
| Shipping | Shipment is carried out on dry-ice for temperature stability to ensure the integrity of the product. |
| Function | The heterodimer formed by ITGAV and ITGB1 (αvβ1 integrin) plays a crucial role in the pathogenesis of diverse conditions, most notably fibrotic disorders (including pulmonary, renal, and hepatic fibrosis) and oncologic progression, where it drives extracellular matrix remodeling, cell invasion, and metastasis. Additionally, αvβ1 is implicated in cardiovascular tissue remodeling, systemic sclerosis, and chronic inflammation associated with autoimmune diseases like rheumatoid arthritis. |
| PubMed ID | 8314844, 7592829, 7542669, 12358597, 12143051 |